You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BEAM Sale Disclosure
Evans John M. · SEC Form 4 · Filed Oct 16, 2026
Sale
Calculated transaction value
$599.6K
Evans John M. CEO
BEAM
Transaction date
Oct 16, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed same day
BEAM daily price context
Close on/before transaction
$23.47
Oct 16, 2026
First close after public filing
$24.19
Oct 19, 2026
Return after filing · so far
+6.7%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 25,000 shares @ $23.98
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-424421
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.24M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Beam Therapeutics Inc. BEAM Current | Sale | Oct 16, 2026 | $599.6K |
| Beam Therapeutics Inc. BEAM | Exercise | Oct 16, 2026 | $0 |
| Beam Therapeutics Inc. BEAM | Exercise | Oct 16, 2026 | $25.75K |
| Beam Therapeutics Inc. BEAM | Exercise | Oct 15, 2026 | $0 |
| Beam Therapeutics Inc. BEAM | Sale | Oct 15, 2026 | $589.15K |
| Beam Therapeutics Inc. BEAM | Exercise | Oct 15, 2026 | $25.75K |